✦ LIBER ✦

Hepatocellular toxicity during the treatment of refractory acute leukemia with indicine N-oxide

✍ Scribed by Louis Letendre; Jurgen Ludwig; Jean Perrault; William A. Smithson; John S. Kovach

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 448 KB
Volume: 54
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19841001)54:7<1256::aid-cncr2820540704>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of indicine N-oxide in refracto

Activity of indicine N-oxide in refractory acute leukemia

✍ Louis Letendre; William A. Smithson; Gerald S. Gilchrist; E. Omer Burgert Jr.; C 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

VP 16–213 and cyclophosphamide in the tr

VP 16–213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features

✍ Hurd, David D. ;Peterson, Bruce A. ;McKenna, Robert W. ;Bloomfield, Clara D. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

## Abstract The treatment of refractory acute nonlymphocytic leukemia remains a major clinical problem in leukemia therapy. VP 16–213 is an investigational agent that may have specificity for monocytic blasts, and the combination of VP 16–213 and cyclophosphamide is synergistic in experimental leuk

Treatment of acute promyelocytic leukemi

Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy

✍ Reiko Watanabe; Shinichiro Okamoto; Takanori Moriki; Masahiro Kizaki; Yoko Kawai 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Response to "Treatment of Childhood Chronic ITP" Prompted by recent correspondence in the Journal (July 1994), may I contribute the experience from this center in the use of megadose prednisone for chronic immune thrombocytopenic purpura (ITP) in children? A cohort of 4 children received this

Diaziquone and 2,2′-anhydro-arabinosyl-5

Diaziquone and 2,2′-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia

✍ Paul A. Meyers; Charlotte T. C. Tan; Peter G. Steinherz; Arlene Redner 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

A phase II study of homoharringtonine fo

A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study

✍ Bell, Beverly A. ;Chang, Myron N. ;Weinstein, Howard J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi

Combination therapy with methotrexate, v

Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

✍ Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Hag 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

BACKGROUND. L-asparaginase in combination with methotrexate has synergistic antileukemic activity in a schedule-dependent fashion. A new preparation of L-asparaginase, polyethylene-glycol conjugated (PEG)-asparaginase, is a pharmacologically different formulation of L-asparaginase with distinct prop